The Hidden Costs of Care Delays
Prior authorization delays don't just inconvenience patients — they create measurable health and financial costs. Research shows that prior authorization delays can worsen outcomes, increase emergency department utilization, and shift costs to patients. A study published in Health Affairs found that prior authorization denials increased emergency department utilization by 4-5% in some specialties.
When clinically appropriate care is delayed, patients often experience disease progression, worse functional outcomes, and sometimes irreversible complications. A patient with severe arthritis waiting 3 months for knee replacement surgery experiences additional joint damage and disability during the waiting period. These downstream costs often exceed the insurer's original "savings" from denial.
Patient Costs from Prior Authorization Delays
Patients face multiple costs from authorization delays: delayed treatment worsens medical conditions, requiring more intensive treatment later; prolonged disability impacts work and lost income; emergency care becomes necessary when delayed planned care leads to acute decompensation; and out-of-pocket costs increase due to higher acuity at treatment.
One study found that a patient requiring an urgent spine surgery who was denied initially and had their appeal delayed 3 months ultimately needed more extensive surgery due to neurological deterioration — increasing the final cost significantly beyond the original approved surgery cost.
Provider and Healthcare System Costs
Healthcare providers spend approximately 14-15 hours per week per provider managing prior authorizations. This administrative burden costs the U.S. healthcare system an estimated $31-40 billion annually. These costs are passed to patients through higher premiums and out-of-pocket costs.
Delays in authorization also strain healthcare systems. Operating rooms remain scheduled but unused during delays. Specialist practices manage numerous authorization requests that could be eliminated with credentialing-based approaches.
The Economic Case for Reducing Prior Authorization
Economic analyses suggest that streamlining prior authorization would reduce overall healthcare costs through: (1) faster disease treatment preventing progression, (2) reduced emergency care utilization, (3) lower administrative costs, and (4) better outcomes at lower total cost. The insurer savings from denied or delayed care are typically outweighed by increased downstream costs.